Circular RNA_ANKIB1 accelerates chemo-resistance of osteosarcoma via binding microRNA-26b-5p and modulating enhancer of zeste homolog 2

References

• Zhao X, Wu Q, Gong X, et al. Osteosarcoma: a review of current and future therapeutic approaches [J]. Biomed Eng Online. 2021;20(1):24.
   PubMed Web of Science ®Google Scholar
• Belayneh R, Fourman MS, Bhogal S, et al. Update on Osteosarcoma [J]. Curr Oncol Rep. 2021;23(6):71.
   PubMed Web of Science ®Google Scholar
• Kager L, Tamamyan G, Bielack S. Novel insights and therapeutic interventions for pediatric osteosarcoma [J]. Future Oncol. 2017;13(4):357–368.
   PubMed Web of Science ®Google Scholar
• Jo VY, Doyle LA. Refinements in sarcoma classification in the current 2013 world health organization classification of tumours of soft tissue and bone [J]. Surg Oncol Clin N Am. 2016;25(4):621–643.
   PubMed Web of Science ®Google Scholar
• König M, Osnes TA, Lobmaier I, et al. Multimodal treatment of craniofacial osteosarcoma with high-grade histology. A single-center experience over 35 years [J]. Neurosurg Rev. 2017;40(3):449–460.
   PubMed Web of Science ®Google Scholar
• Casali PG, Bielack S, Abecassis N, et al. Bone sarcomas: ESMO-PaedCan-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up [J]. Ann Oncol. 2018;29(Suppl 4):iv79–iv95.
   PubMedGoogle Scholar
• Tang Q, Hann SS. Biological roles and mechanisms of circular RNA in human cancers [J]. Onco Targets Ther. 2020;13:2067–2092.
   PubMed Web of Science ®Google Scholar
• Yu D, Zhang S, Feng A, et al. Methotrexate, doxorubicin, and cisplatinum regimen is still the preferred option for osteosarcoma chemotherapy: a meta-analysis and clinical observation [J]. Medicine (Baltimore). 2019;98(19):e15582–e15582.
   PubMed Web of Science ®Google Scholar
• Wang SY, Hu HZ, Qing XC, et al. Recent advances of drug delivery nanocarriers in osteosarcoma treatment [J]. J Cancer. 2020;11(1):69–82.
   PubMed Web of Science ®Google Scholar
• Barrett SP, Salzman J. Circular RNAs: analysis, expression and potential functions [J]. Development. 2016;143(11):1838–1847.
   PubMed Web of Science ®Google Scholar
• Wang S, Claret FX, and Wu W. MicroRNAs as therapeutic targets in nasopharyngeal carcinoma [J]. Front Oncol. 2019;13(9):756.
   Web of Science ®Google Scholar
• Zhu X, Liu C, Shi J, et al. Circular RNA circANKIB1 promotes the progression of osteosarcoma by regulating miR-217/PAX3 axis [J]. J Bone Oncol. 2021;27(100347):100347.
   PubMedGoogle Scholar
• Du YX, Guo LX, Pan HS, et al. Circ_ANKIB1 stabilizes the regulation of miR-19b on SOCS3/STAT3 pathway to promote osteosarcoma cell growth and invasion [J]. Hum Cell. 2020;33(1):252–260.
   PubMed Web of Science ®Google Scholar
• Mirahmadi Y, Nabavi R, Taheri F, et al. MicroRNAs as biomarkers for early diagnosis, prognosis, and therapeutic targeting of ovarian cancer [J]. J Oncol. 2021;2021(3408937):1–25.
   Google Scholar
• Lin Z, Xie X, Lu S, et al. Noncoding RNAs in osteosarcoma: implications for drug resistance [J]. Cancer Lett. 2021;504:91–103.
   PubMed Web of Science ®Google Scholar
• Li G, Li Y, Wang DY. Overexpression of miR-329-3p sensitizes osteosarcoma cells to cisplatin through suppression of glucose metabolism by targeting LDHA [J]. Cell Biol Int. 2021;45(4):766–774.
   PubMed Web of Science ®Google Scholar
• Yang D, Xu T, Fan L, et al. microRNA-216b enhances cisplatin-induced apoptosis in osteosarcoma MG63 and SaOS-2 cells by binding to JMJD2C and regulating the HIF1α/HES1 signaling axis [J]. J Exp Clin Cancer Res. 2020;39(1):201.
   PubMed Web of Science ®Google Scholar
• Wu Q, Feng Q, Xiong Y, et al. RAB31 is targeted by miR-26b and serves a role in the promotion of osteosarcoma [J]. Oncol Lett. 2020;20(5):244.
   PubMed Web of Science ®Google Scholar
• Zhu Z, Tang J, Wang J, et al. MiR-138 acts as a tumor suppressor by targeting EZH2 and enhances cisplatin-induced apoptosis in osteosarcoma cells [J]. PLoS One. 2016;11(3):e0150026.
   PubMed Web of Science ®Google Scholar
• Ayuk SM, Abrahamse H, Houreld NN. The role of photobiomodulation on gene expression of cell adhesion molecules in diabetic wounded fibroblasts in vitro [J]. J Photochem Photobiol B. 2016;161:368–374.
   PubMed Web of Science ®Google Scholar
• Wu Y, Xie Z, Chen J, et al. Circular RNA circTADA2A promotes osteosarcoma progression and metastasis by sponging miR-203a-3p and regulating CREB3 expression [J]. Mol Cancer. 2019;18(1):73.
   PubMed Web of Science ®Google Scholar
• Hu S, Li J, Tong M, et al. MicroRNA‑144‑3p may participate in the pathogenesis of preeclampsia by targeting Cox‑2 [J]. Mol Med Rep. 2019;19(6):4655–4662.
   PubMed Web of Science ®Google Scholar
• Li W, Zheng G, Xia J, et al. Cell cycle‐related and expression‐elevated protein in tumor overexpression is associated with proliferation behaviors and poor prognosis in non‐small‐cell lung cancer [J]. Cancer Sci. 2018;109(4):1012–1023.
   PubMed Web of Science ®Google Scholar
• Li Z, Qin X, Bian W, et al. Exosomal lncRNA ZFAS1 regulates esophageal squamous cell carcinoma cell proliferation, invasion, migration and apoptosis via microRNA-124/STAT3 axis [J]. J Exp Clin Cancer Res. 2019;38(1):1–13.
   PubMed Web of Science ®Google Scholar
• Xu M, Cao F-L, Li N, et al. Leptin induces epithelial-to-mesenchymal transition via activation of the ERK signaling pathway in lung cancer cells [J]. Oncol Lett. 2018;16(4):4782–4788.
   PubMed Web of Science ®Google Scholar
• Xing Z, Zhang Z, Gao Y, et al. The lncRNA LINC01194/miR-486-5p axis facilitates malignancy in non-small cell lung cancer via regulating CDK4 [J]. Onco Targets Ther. 2020 3151;13:3151–3163.
   PubMed Web of Science ®Google Scholar
• Yuan J, Liu Y, Zhang Q, et al. CircPRDM2 contributes to doxorubicin resistance of osteosarcoma by elevating EZH2 via sponging miR-760 [J]. Cancer Manag Res. 2021;13:4433–4445.
   PubMed Web of Science ®Google Scholar
• Zhang B, Zhang Y, Li R, et al. The efficacy and safety comparison of first-line chemotherapeutic agents (high-dose methotrexate, doxorubicin, cisplatin, and ifosfamide) for osteosarcoma: a network meta-analysis [J]. J Orthop Surg Res. 2020;15(1):51.
   PubMed Web of Science ®Google Scholar
• Buondonno I, Gazzano E, Jean SR, et al. Mitochondria-targeted doxorubicin: a new therapeutic strategy against doxorubicin-resistant osteosarcoma [J]. Mol Cancer Ther. 2016;15(11):2640–2652.
   PubMed Web of Science ®Google Scholar
• Yin Y, Long J, He Q, et al. Emerging roles of circRNA in formation and progression of cancer [J]. J Cancer. 2019;10(21):5015–5021.
   PubMed Web of Science ®Google Scholar
• Kun-Peng Z, Xiao-Long M, Lei Z, et al. Screening circular RNA related to chemotherapeutic resistance in osteosarcoma by RNA sequencing [J]. Epigenomics. 2018;10(10):1327–1346.
   PubMed Web of Science ®Google Scholar
• Ji Y, Liu J, Zhu W, et al. circ_0002060 enhances doxorubicin resistance in osteosarcoma by regulating the miR-198/ABCB1 axis [J]. Cancer Biother Radiopharm. 2020.DOI:10.1089/cbr.2020.4240.
   Web of Science ®Google Scholar
• Guan H, Xu H, Chen J, et al. Circ_0001721 enhances doxorubicin resistance and promotes tumorigenesis in osteosarcoma through miR-758/TCF4 axis [J]. Cancer Cell Int. 2021;21(1):336.
   PubMed Web of Science ®Google Scholar
• Hu Y, Gu J, Shen H, et al. Circular RNA LARP4 correlates with decreased enneking stage, better histological response, and prolonged survival profiles, and it elevates chemosensitivity to cisplatin and doxorubicin via sponging microRNA-424 in osteosarcoma [J]. J Clin Lab Anal. 2020;34(2):e23045.
   PubMed Web of Science ®Google Scholar
• Bracken CP, Scott HS, Goodall GJ. A network-biology perspective of microRNA function and dysfunction in cancer [J]. Nat Rev Genet. 2016;17(12):719–732.
   PubMed Web of Science ®Google Scholar
• Han F, Huang D, Huang X, et al. Exosomal microRNA-26b-5p down-regulates ATF2 to enhance radiosensitivity of lung adenocarcinoma cells [J]. J Cell Mol Med. 2020;24(14):7730–7742.
   PubMed Web of Science ®Google Scholar
• Zhou A, Pan H, Sun D, et al. miR-26b-5p inhibits the proliferation, migration and invasion of human papillary thyroid cancer in a β-catenin-dependent manner [J]. Onco Targets Ther. 2020;13:1593–1603.
   PubMedGoogle Scholar
• Niu F, Kazimierska M, Nolte IM, et al. The mir-26b-5p/kpna2 axis is an important regulator of burkitt lymphoma cell growth [J]. Cancers (Basel). 2020;12(6):1464.
   PubMed Web of Science ®Google Scholar
• Di Leva G, Garofalo M, Croce CM. MicroRNAs in cancer [J]. Annu Rev Pathol. 2014;9:287–314.
   PubMed Web of Science ®Google Scholar